Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Allergic Rhinitis
  • Asthma
  • Atopic Dermatitis
  • Cardiovascular
    • Cardiovascular
    • Atherothrombosis
    • Dyslipidemia
    • Thrombosis
  • Diabetes
  • Eosinophilic Esophagitis
  • Multiple Sclerosis
  • Nasal Polyps
  • Prurigo Nodularis
  • Oncology and Rare Blood Disorder
    • Oncology and Rare Blood Disorder
    • Multiple Myeloma
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Meningitis
    • Pertussis & Polio
    • RSV
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Allergic Rhinitis
  • Atopic Dermatitis
  • Cardiovascular
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • My Dose Coach
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
      • Clinical and economic value of SOLIQUA - Pharmacist perspective
  • Nasal Polyps
  • Rare Diseases
PRODUCTS
  • PRODUCTS
  • Amaryl®
  • Apidra®
  • Aprovasc®
  • Aprovel®
  • Aubagio®
  • Clexane®
  • Depakine®
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Lantus®
  • Plavix®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Sarclisa
    • Sarclisa
    • Sarclisa®
    • Sarclisa Kd®
    • Sarclisa Pd®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
    • Soli-Simplify Study
  • Tavanic®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
    • Real world Evidences
  • Zympass®
LOGIN
REGISTER
SEARCH
Home | go to homepage
LOGIN
REGISTER
SEARCH
Home | go to homepage
SCIENCE
  • SCIENCE
  • Allergic Rhinitis
  • Asthma
  • Atopic Dermatitis
  • Cardiovascular
    • Cardiovascular
    • Atherothrombosis
    • Dyslipidemia
    • Thrombosis
  • Diabetes
  • Eosinophilic Esophagitis
  • Multiple Sclerosis
  • Nasal Polyps
  • Prurigo Nodularis
  • Oncology and Rare Blood Disorder
    • Oncology and Rare Blood Disorder
    • Multiple Myeloma
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Meningitis
    • Pertussis & Polio
    • RSV
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Allergic Rhinitis
  • Atopic Dermatitis
  • Cardiovascular
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • My Dose Coach
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
      • Clinical and economic value of SOLIQUA - Pharmacist perspective
  • Nasal Polyps
  • Rare Diseases
PRODUCTS
  • PRODUCTS
  • Amaryl®
  • Apidra®
  • Aprovasc®
  • Aprovel®
  • Aubagio®
  • Clexane®
  • Depakine®
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Lantus®
  • Plavix®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Sarclisa
    • Sarclisa
    • Sarclisa®
    • Sarclisa Kd®
    • Sarclisa Pd®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
    • Soli-Simplify Study
  • Tavanic®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
    • Real world Evidences
  • Zympass®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Science
    • Inspiration and Innovation

    Inspiration and Innovation

    Get inspired and stay on the cutting edge of innovation with these resources.

    Filters

    Therapeutical Areas
    Cardiovascular
    Diabetes
    Atopic Dermatitis
    Asthma
    Nasal Polyps
    Rare diseases
    Vaccines
    Influenza
    Multiple Sclerosis

    How do you choose the right biologic for a particular asthma patients?

    When do you discuss biologic treatment with your asthma patients?

    What Challenges do you face when treating patients with Type 2 inflammation?

    How type 2 inflammation affect patients with Asthma?

    Why is it important to look for type 2 inflammation in patients with Asthma?

    How do you balance the cost of biologics with the value they can bring to patients?

    DUPIXENT Asthma KOL Expert Series Video - Exacerbations

    DUPIXENT Asthma KOL Expert Series Video - DUPIXENT in Your Practice

    DUPIXENT Asthma KOL Expert Series Video - Lung Function

    DUPIXENT Asthma KOL Expert Series Video - OCS-Sparing

    DUPIXENT Asthma KOL Expert Series Video - DUPIXENT Patient Perspective

    DUPIXENT Asthma KOL Expert Series Video - Quality of Life

    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    Home | go to homepage

    SANOFI, Kingdom of Saudi Arabia, P.O. Box 9874, Jeddah 21423, K.S.A. Tel: +966-12-669-3318,

    Fax: +966-12-663-6191

    For Medical Information, please contact: +966-12-669-3318, ksa.medicalinformation@sanofi.com

    To report any Product Technical Complaints, kindly contact: Email: quality.greatergulf@sanofi.com

    In case of any drug related adverse events, please contact:

    The National Pharmacovigilance Center (NPC):

    Call Center: 19999, E-mail: npc.drug@sfda.gov.sa, Website: https://ade.sfda.gov.sa/

    And Sanofi Pharmacovigilance Department:

    Phone: +966-544-284-797, E-mail: Ksa_pharmacovigilance@sanofi.com

     

    MAT-SA-2100978/V4/NOV 2022

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.